x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Pharmaceutical Executive

Pharmaceutical Executive Podcast

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

science life sciences

All Episodes

2:46

Pharmaceutical Executive Daily: September 15, 2025

Pharmaceutical Executive ·

2025/09/15

en-us

2:30

Pharmaceutical Executive Daily: September 12, 2025

Pharmaceutical Executive ·

2025/09/12

Today's episode covers the president’s call to lower drug costs for patients, the compliance and operational pressures facing pharmaceutical manufacturers, and a White House plan to restrict treatments discovered in China.

en-us

2:33

Pharmaceutical Executive Daily: September 11, 2025

Pharmaceutical Executive ·

2025/09/11

In today’s Pharmaceutical Executive Daily, we cover Lundbeck’s restructuring affecting more than 600 international employees, Novo Nordisk’s global plan to cut 9,000 jobs, and former President Trump’s push to rein in pharmaceutical direct-to-consumer advertising.

en-us

2:32

Pharmaceutical Executive Daily: September 9, 2025

Pharmaceutical Executive ·

2025/09/09

In today’s Pharmaceutical Executive Daily, we explore strategies to strengthen pharma sales messaging, the role of AI-driven simulations in field rep training, and the FDA’s updated Green List restricting ingredients used in GLP-1 compounding.

en-us

2:27

Pharmaceutical Executive Daily: September 8, 2025

Pharmaceutical Executive ·

2025/09/08

en-us

2:32

Pharmaceutical Executive Daily: September 5, 2025

Pharmaceutical Executive ·

2025/09/05

In today’s Pharmaceutical Executive Daily, we will recap the top stories of the week, exploring the current state of the GLP-1 market, review major pharmaceutical layoffs shaping 2025, and cover Pfizer’s response to political pressure on COVID-19 vaccine safety evidence.

en-us

2:32

Pharmaceutical Executive Daily: September 4, 2025

Pharmaceutical Executive ·

2025/09/04

In today’s Pharmaceutical Executive Daily, we cover political pressure on Moderna and Novavax to release COVID-19 vaccine evidence, a deep dive into the evolving GLP-1 market, and Sanofi’s share decline following disappointing Phase III results for Amlitelimab.

en-us

2:09

Pharmaceutical Executive Daily: September 3, 2025

Pharmaceutical Executive ·

2025/09/03

In today’s Pharmaceutical Executive Daily, we cover Pfizer’s response to political pressure over COVID-19 vaccine safety data, Cheryl Reicin’s outlook on future GLP-1 investment, and Novartis’ $5.2 billion acquisition of Argo Biopharmaceuticals.

en-us

14:39

The Rx for High-Performance Leadership: Cutting...

Pharmaceutical Executive ·

2025/08/22

In a turbulent era for biopharma, leadership demands clarity, resilience, and adaptability. In this candid podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, shares high-level insights on what CEOs can do to thrive amid the disruption—from regulatory agility to cultural resilience. The corporate strategy expert explains why the best leaders are the best learners—and how prioritization, honesty, and boldness will separate those who merely survive from those who

en-us

2:08

Pharmaceutical Executive Weekly:CSL Cuts Jobs,...

Pharmaceutical Executive ·

2025/08/21

In this week’s Pharmaceutical Executive Weekly, we cover CSL’s decision to cut 15% of its U.S. workforce and close 22 plasma centers, Pfizer’s Phase 3 trial failure in sickle cell disease, and Eli Lilly’s new LillyDirect program expanding full-dose Zepbound access for obesity patients.

en-us

17:26

Addressing Disparities in Psoriasis Trials: Takeda's...

Pharmaceutical Executive ·

2025/04/14

LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, discusses strategies to address underrepresentation in phase III psoriasis trials. She also talks about Takeda's partnerships with community stakeholders like Inside Edge, Black Health Matters, and Hispanic Communication Global Network to help improve engagement, address operational barriers by incorporating multicultural imagery, and prioritize sites with diverse patient demographics. She also explains how they've enhanced

en-us

17:36

Tariffs and Drug Prices: Understanding the Impact on...

Pharmaceutical Executive ·

2025/03/24

In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses:The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts. How digital health platforms, like UpScriptHealth, can help reduce friction and costs in healthcare, potentially offsetting tariff impacts The importance of telehealth in ensuring

en-us

24:22

The Misinformation Maze: Navigating Public Health in...

Pharmaceutical Executive ·

2025/03/11

In this episode of the Pharmaceutical Executive podcast, Jennifer Butler, Chief Commercial Officer of Pleio, discusses: The threat of misinformation to public health and how emotional appeal plays a part Where patients are turning for trustworthy health information Strategies that can be used to verify information Pharma's role in helping to ensure patients have access to health insights they can trust Why the industry is turning to peer-to-patient platforms, trusted patient communities, and

en-us

26:45

Navigating Distrust: Pharma in the Age of Social Media

Pharmaceutical Executive ·

2025/02/18

In this episode of the Pharmaceutical Executive Podcast, CEO and Founder of Sooth, Ian Baer, is back to discuss:The growing distrust in social media Why people trust friends and influencers over companies The EMA's departure from X Concerns about information accessibility The healthcare industry's trust gap "Dark Social" and SO MUCH MORE! Pharmaceutical Executive has a brand new look! Click through our February issue here:

en-us

19:23

Revolutionizing Patient Adherence: Leveraging AI for...

Pharmaceutical Executive ·

2025/02/10

In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence. By utilizing patient-level data and predictive modeling, AI can identify individual needs and preferences, tailoring interventions to optimize treatment outcomes. This personalized approach addresses the common challenges of medication non-adherence and improves patient outcomes. The discussion highlights the importance of

en-us

30:12

The Future of Fertility: AI, Personalized Medicine,...

Pharmaceutical Executive ·

2025/01/30

In this episode of the Pharmaceutical Executive podcast, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses the challenges of addressing fertility misinformation on social media. He emphasizes the importance of providing accurate and reliable information and encourages patients to consult with healthcare professionals. He also discusses the ethical considerations of using social media to share personal and professional experiences in the field of fertility

en-us

13:20

Key Findings of the NIAGARA and HIMALAYA Trials

Pharmaceutical Executive ·

2024/11/08

In this episode of the Pharmaceutical Executive podcast, Shubh Goel, Head of Immuno-Oncology and Gastrointestinal Tumors, US Oncology Business Unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer, and much more.

en-us

21:15

Fake Weight Loss Drugs: Growing Threat to Consumer...

Pharmaceutical Executive ·

2024/10/25

UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss:Counterfeit weight loss drugs (particularly fake Ozempic) and potential health risks What can be done to raise awareness among consumers about the dangers of counterfeit medications Ways increase access to legitimate weight loss medications, especially for those in underserved communities and much more!

en-us

14:52

A Different Approach to Dermatology Care

Pharmaceutical Executive ·

2024/09/23

Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses how is they're positioning to capitalize on the unmet needs in other specific therapeutic areas, their approach to orphan drug development, challenges and opportunities adapting to the US market, and more.

en-us

15:48

Beyond the Birthrate: The Societal Costs of Maternal...

Pharmaceutical Executive ·

2024/09/06

In this episode of the Pharmaceutical Executive podcast, Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discusses:The broader societal implications of these maternal health issues highlighted in The Commonwealth Fund study The most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make Specific efforts Organon is undertaking to invest in research, education, and its pipeline to focus on critical

en-us

229 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter